Transgenic Goat Antithrombin Gains EU Nod
This article was originally published in The Pink Sheet Daily
Executive Summary
GTC Biotherapeutics' recombinant human antithrombin ATryn was granted European Union marketing authorization roughly six months after receiving an initial negative opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use